Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1994 Aug;86(8):583–591.

Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

S S Coughlin 1, J S Gottdiener 1, K L Baughman 1, A Wasserman 1, E S Marx 1, M C Tefft 1, B J Gersh 1
PMCID: PMC2607718  PMID: 7932836

Abstract

Racial, socioeconomic, and clinical factors were examined as predictors of survival in idiopathic dilated cardiomyopathy using cases from five Washington, DC-area hospitals. One hundred three (80.5%) of the patients were black and 25 (19.5%) were white. The black patients were less likely to have private health insurance, less educated on average, and more likely to have a household income of $15,000 or less (P < or = .05). No racial differences were found in cardiac medication usage, with the exception of beta blockers and antiarrhythmics. The cumulative survival among black patients at 12 and 24 months was 71.5% and 63.6%, respectively, as compared with 92.0% and 86.3% among whites. The 12-month survival of black patients with ventricular arrhythmias or an ejection fraction of less than 25% was particularly poor. Age, ventricular arrhythmias, ejection fraction, and cigarette usage were significant predictors of survival in univariate analysis using the proportional hazards model. The univariate association with black race was of borderline significance (P < or = .07). In multivariate analysis, age and race were statistically significant independent predictors of survival. A strong association with black race was observed with an estimated relative risk of mortality of 5.41 (P < or = .02) after adjustment for age, ejection fraction, ventricular arrhythmias, and educational attainment. Poorer survival among blacks may be caused by a greater severity of disease at the time of diagnosis or by racial differences in cardiac care, comorbid conditions, or biologic factors affecting survival.

Full text

PDF
583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camerini F., Bussani R., Lenarda D., Lardieri G., Mestroni L., Miani D., Pinamonti B., Salvi A., Silvestri F., Sinagra G. Clinical aspects and haemodynamics in the follow-up of dilated cardiomyopathy and myocarditis. Eur Heart J. 1991 Aug;12 (Suppl 500):193–196. doi: 10.1093/eurheartj/12.suppl_d.193. [DOI] [PubMed] [Google Scholar]
  2. Coughlin S. S., Labenberg J. R., Tefft M. C. Black-white differences in idiopathic dilated cardiomyopathy: the Washington DC dilated Cardiomyopathy Study. Epidemiology. 1993 Mar;4(2):165–172. doi: 10.1097/00001648-199303000-00013. [DOI] [PubMed] [Google Scholar]
  3. Coughlin S. S., Neaton J. D., Sengupta A., Kuller L. H. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1994 Jan 15;139(2):166–172. doi: 10.1093/oxfordjournals.aje.a116978. [DOI] [PubMed] [Google Scholar]
  4. Coughlin S. S., Pearle D. L., Baughman K. L., Wasserman A., Tefft M. C. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. Ann Epidemiol. 1994 Jan;4(1):67–74. doi: 10.1016/1047-2797(94)90044-2. [DOI] [PubMed] [Google Scholar]
  5. Coughlin S. S., Szklo M., Baughman K., Pearson T. A. The epidemiology of idiopathic dilated cardiomyopathy in a biracial community. Am J Epidemiol. 1990 Jan;131(1):48–56. doi: 10.1093/oxfordjournals.aje.a115484. [DOI] [PubMed] [Google Scholar]
  6. Coughlin S. S. Toward the primary prevention of idiopathic dilated cardiomyopathy. J Natl Med Assoc. 1991 Nov;83(11):949–950. [PMC free article] [PubMed] [Google Scholar]
  7. Criqui M. H., Wallace R. B., Mishkel M., Barrett-Connor E., Heiss G. Alcohol consumption and blood pressure. The lipid research clinics prevalence study. Hypertension. 1981 Sep-Oct;3(5):557–565. doi: 10.1161/01.hyp.3.5.557. [DOI] [PubMed] [Google Scholar]
  8. De Maria R., Gavazzi A., Caroli A., Ometto R., Biagini A., Camerini F. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Italian Multicenter Cardiomyopathy Study (SPIC) Group. Am J Cardiol. 1992 Jun 1;69(17):1451–1457. doi: 10.1016/0002-9149(92)90900-j. [DOI] [PubMed] [Google Scholar]
  9. Diaz R. A., Obasohan A., Oakley C. M. Prediction of outcome in dilated cardiomyopathy. Br Heart J. 1987 Oct;58(4):393–399. doi: 10.1136/hrt.58.4.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Franciosa J. A., Wilen M., Ziesche S., Cohn J. N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983 Mar 1;51(5):831–836. doi: 10.1016/s0002-9149(83)80141-6. [DOI] [PubMed] [Google Scholar]
  11. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981 Mar;47(3):525–531. doi: 10.1016/0002-9149(81)90534-8. [DOI] [PubMed] [Google Scholar]
  12. Gavazzi A., De Maria R., Renosto G., Moro A., Borgia M., Caroli A., Castelli G., Ciaccheri M., Pavan D., De Vita C. The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group. Am Heart J. 1993 Feb;125(2 Pt 1):410–422. doi: 10.1016/0002-8703(93)90020-a. [DOI] [PubMed] [Google Scholar]
  13. Gillum R. F. Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J. 1986 Apr;111(4):752–755. doi: 10.1016/0002-8703(86)90111-0. [DOI] [PubMed] [Google Scholar]
  14. Hatle L., Stake G., Storstein O. Chronic myocardial disease. II. Haemodynamic findings related to long-term prognosis. Acta Med Scand. 1976;199(5):407–411. [PubMed] [Google Scholar]
  15. Juillière Y., Danchin N., Briançon S., Khalife K., Ethévenot G., Balaud A., Gilgenkrantz J. M., Pernot C., Cherrier F. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol. 1988 Dec;21(3):269–277. doi: 10.1016/0167-5273(88)90104-0. [DOI] [PubMed] [Google Scholar]
  16. Kelly T. L., Cremo R., Nielsen C., Shabetai R. Prediction of outcome in late-stage cardiomyopathy. Am Heart J. 1990 May;119(5):1111–1121. doi: 10.1016/s0002-8703(05)80242-x. [DOI] [PubMed] [Google Scholar]
  17. Komajda M., Jais J. P., Reeves F., Goldfarb B., Bouhour J. B., Juillieres Y., Lanfranchi J., Peycelon P., Geslin P., Carrie D. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 1990 Sep;11(9):824–831. doi: 10.1093/oxfordjournals.eurheartj.a059803. [DOI] [PubMed] [Google Scholar]
  18. Manolio T. A., Baughman K. L., Rodeheffer R., Pearson T. A., Bristow J. D., Michels V. V., Abelmann W. H., Harlan W. R. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol. 1992 Jun 1;69(17):1458–1466. doi: 10.1016/0002-9149(92)90901-a. [DOI] [PubMed] [Google Scholar]
  19. Olshausen K. V., Stienen U., Schwarz F., Kübler W., Meyer J. Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1988 Jan 1;61(1):146–151. doi: 10.1016/0002-9149(88)91321-5. [DOI] [PubMed] [Google Scholar]
  20. Redfield M. M., Gersh B. J., Bailey K. R., Ballard D. J., Rodeheffer R. J. Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol. 1993 Dec;22(7):1921–1926. doi: 10.1016/0735-1097(93)90780-5. [DOI] [PubMed] [Google Scholar]
  21. Romeo F., Pelliccia F., Cianfrocca C., Gallo P., Barilla F., Cristofani R., Reale A. Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol. 1989 Jul;12(7):387–392. doi: 10.1002/clc.4960120708. [DOI] [PubMed] [Google Scholar]
  22. Sugrue D. D., Rodeheffer R. J., Codd M. B., Ballard D. J., Fuster V., Gersh B. J. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med. 1992 Jul 15;117(2):117–123. doi: 10.7326/0003-4819-117-2-117. [DOI] [PubMed] [Google Scholar]
  23. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES